Characterization of Colibactin-Producing Escherichia coli Isolated from Japanese Patients with Colorectal Cancer - PubMed

Affiliations

• PMID: 32475872
• DOI: 10.7883/yoken.JJID.2020.066

Free article

Characterization of Colibactin-Producing Escherichia coli Isolated from Japanese Patients with Colorectal Cancer

Yuko Yoshikawa et al. Jpn J Infect Dis. 2020.

Free article

Abstract

We investigated the relationship between colibactin-producing (clb⁺) Escherichia coli and colorectal adenocarcinoma. In total, 729 E. coli colonies were isolated from tumor and surrounding non-tumor regions in resected specimens from 34 Japanese patients; 450 colonies were from the tumor regions and 279 from the non-tumor regions. clb⁺ bacteria were found in tumor regions of 11 patients (11/34, 32.4%) and they were also detected in the non-tumor regions of 7 out of these 11 patients (7/34, 20.6%). The prevalence of clb⁺ isolates was 72.7% (327/450) and 44.1% (123/279) in tumor and non-tumor regions, respectively. All the recovered clb⁺ isolates belonged to the phylogenetic group B2 and were the most predominant type in tumor regions. Hemolytic (α-hemolysin-positive, hlyA⁺) and non-hemolytic (α-hemolysin-negative, hlyA^-) clb⁺ isolates were obtained from patient #19; however, the prevalence of hlyA⁺ clb⁺ isolates was significantly higher in tumor regions (35/43, 81.4%) than in non-tumor regions (3/19, 15.8%). Moreover, a significantly higher production of N-myristoyl-D-asparagine, a by-product of colibactin biosynthesis, was observed in hlyA⁺ clb⁺ isolates than in hlyA^- clb⁺ isolates. Our results suggest that hlyA⁺ clb⁺ E. coli may have a selective advantage in colorectal colonization and, consequently, might play a role in carcinogenesis. The presence of hlyA⁺ clb⁺ bacteria in healthy individuals is a potential risk marker of colorectal cancer.

Keywords: colibactin; colorectal cancer; commensal Escherichia coli; hemolytic activity.

Similar articles

• Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.

  Tariq H, Noreen Z, Ahmad A, Khan L, Ali M, Malik M, Javed A, Rasheed F, Fatima A, Kocagoz T, Sezerman U, Bokhari H. Tariq H, et al. PLoS One. 2022 Nov 11;17(11):e0262662. doi: 10.1371/journal.pone.0262662. eCollection 2022. PLoS One. 2022. PMID: 36367873 Free PMC article.

• In vitro genotoxicity analyses of colibactin-producing E. coli isolated from a Japanese colorectal cancer patient.

  Kawanishi M, Hisatomi Y, Oda Y, Shimohara C, Tsunematsu Y, Sato M, Hirayama Y, Miyoshi N, Iwashita Y, Yoshikawa Y, Sugimura H, Mutoh M, Ishikawa H, Wakabayashi K, Yagi T, Watanabe K. Kawanishi M, et al. J Toxicol Sci. 2019;44(12):871-876. doi: 10.2131/jts.44.871. J Toxicol Sci. 2019. PMID: 31813906

• Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria.

  Tsunematsu Y, Hosomi K, Kunisawa J, Sato M, Shibuya N, Saito E, Murakami H, Yoshikawa Y, Iwashita Y, Miyoshi N, Mutoh M, Ishikawa H, Sugimura H, Miyachi M, Wakabayashi K, Watanabe K. Tsunematsu Y, et al. BMC Microbiol. 2021 Aug 24;21(1):235. doi: 10.1186/s12866-021-02292-1. BMC Microbiol. 2021. PMID: 34429063 Free PMC article.

• Carriage of Colibactin-producing Bacteria and Colorectal Cancer Risk.

  Dubinsky V, Dotan I, Gophna U. Dubinsky V, et al. Trends Microbiol. 2020 Nov;28(11):874-876. doi: 10.1016/j.tim.2020.05.015. Epub 2020 Jun 5. Trends Microbiol. 2020. PMID: 32507544 Review.

• E. coli and colorectal cancer: a complex relationship that deserves a critical mindset.

  Wassenaar TM. Wassenaar TM. Crit Rev Microbiol. 2018 Sep;44(5):619-632. doi: 10.1080/1040841X.2018.1481013. Epub 2018 Jun 17. Crit Rev Microbiol. 2018. PMID: 29909724 Review.

Cited by

• Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features.

  Nouri R, Hasani A, Masnadi Shirazi K, Alivand MR, Sepehri B, Sotoudeh S, Hemmati F, Fattahzadeh A, Abdinia B, Ahangarzadeh Rezaee M. Nouri R, et al. Can J Infect Dis Med Microbiol. 2021 Nov 9;2021:2131787. doi: 10.1155/2021/2131787. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34795808 Free PMC article.

• Evolutionary Dynamics Based on Comparative Genomics of Pathogenic Escherichia coli Lineages Harboring Polyketide Synthase (pks) Island.

  Suresh A, Shaik S, Baddam R, Ranjan A, Qumar S, Jadhav S, Semmler T, Ghazi IA, Wieler LH, Ahmed N. Suresh A, et al. mBio. 2021 Mar 2;12(1):e03634-20. doi: 10.1128/mBio.03634-20. mBio. 2021. PMID: 33653937 Free PMC article.

• Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review.

  Mezerova K, Raclavsky V, Stary L. Mezerova K, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):1-11. doi: 10.5507/bp.2021.054. Epub 2021 Nov 5. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022. PMID: 34747413 Review.

• Oligosaccharides increase the genotoxic effect of colibactin produced by pks+ Escherichia coli strains.

  Oliero M, Calvé A, Fragoso G, Cuisiniere T, Hajjar R, Dobrindt U, Santos MM. Oliero M, et al. BMC Cancer. 2021 Feb 17;21(1):172. doi: 10.1186/s12885-021-07876-8. BMC Cancer. 2021. PMID: 33596864 Free PMC article.

• Cyclomodulins and Hemolysis in E. coli as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening.

  Mezerová K, Starý L, Zbořil P, Klementa I, Stašek M, Špička P, Skalický P, Raclavský V. Mezerová K, et al. Life (Basel). 2021 Oct 31;11(11):1165. doi: 10.3390/life11111165. Life (Basel). 2021. PMID: 34833041 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • J-STAGE, Japan Science and Technology Information Aggregator, Electronic

• Medical

  • MedlinePlus Health Information